openPR Logo
Press release

Drug Delivery Systems market is growing at a high cagr by 2027 according to a new research report by BD, Novo Nordisk A/S, 3M, Boston Scientific Corporation, Bausch Health Companies

07-09-2019 06:53 PM CET | Health & Medicine

Press release from: The Insight Partners

Drug Delivery Systems market is growing at a high cagr by 2027

Drug Delivery Systems market is among the fastest-growing branches of economy. To be successful in this rapidly evolving, highly competitive sector, companies need high-quality, up-to-date information and insight. The insight partners research publications have been providing research and market analysis services for the Drug Delivery Systems sectors.

The global drug delivery systems market accounted to US$ 1,243.1 Bn in 2018 and is expected to grow at a CAGR of 7.2% during the forecast period 2019 – 2027, to account to US$ 2,302.2 Bn by 2027.

Get pdf sample copy of research report https://www.theinsightpartners.com/sample/TIPHE100000854/?utm_source=opr&utm_medium=NB

Asia Pacific is the fastest growing geographic market and it is expected to be the second largest revenue contributor throughout the forecast period. The growth is contributed majorly by driving factors such as significant rise in the prevalence of chronic diseases across the countries, rise in the government support for the patient population. In addition, the market players are also developing novel products in the countries through robust R&D activities and partnerships and acquisitions.

The List of Companies
BD (Becton Dickinson & Company)
Boston Scientific Corporation
Novo Nordisk A/S
Bausch Health Companies Inc.
Baxter International, Inc.
Boehringer Ingelheim
Novartis AG
GlaxoSmithKline plc.
Johnson & Johnson Services, Inc.
Terumo Corporation

Rising Incidence of Chronic Diseases
Over the past few decades, Research and development (R&D) in drug delivery devices is increasing across the globe due to increasing prevalence of chronic disease. Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans. Various routes of administration are being studied in order to treat these chronic diseases. According to the Centers for Disease Control and Prevention (CDC) in the 2019, almost 6 in 10 people in the US suffer from at least one chronic disease and 4 in 10 people have two or more chronic diseases.
Some important technological advantages of nanotherapeutic drug delivery systems (NDDS) include prolonged half-life, improved bio-distribution, increased circulation time of the drug, controlled and sustained release of the drug, versatility of route of administration, increased intercellular concentration of drug and many more.

Growing Demand for Non Invasive Drug Delivery Devices
With the improvements in medical devices and certain transdermal delivery technologies, the non-invasive mode of drug delivery is now ready to compete with traditional methods of oral and injectible routes of drug delivery. The Non-Invasive Drug Delivery Systems encompasses the broad field of non-invasive drug delivery systems which includes drug delivery via topical, transdermal-active (device- aided enhanced penetration), transdermal-passive, trans-ocular membrane, trans-mucosal membrane, as well as delivery via alveolar membrane from inhaled medication. Patient compliance has been found to be much higher when administrated by non-invasive routes due to decreased pain involved in drug delivery and therefore these techniques are considered to be a preferred mode of drug delivery.

Get discount on this report@ https://www.theinsightpartners.com/discount/TIPHE100000854/?utm_source=opr&utm_medium=NB

Product Insights
The global drug delivery systems market by product segments was led by oral drug delivery segment. In 2018, the oral drug delivery segment held a largest market share of 50.2% of the drug delivery systems market, by route of administration. The transmucosal segment is expected to be the fastest growing segments the market in 2027 owing to rapidly rising incidence of chronic disorders, including gastrointestinal, respiratory, and autoimmune disorders.

The insight partners,
Call: +1-646-491-9876
email: sales@theinsightpartners.com
Website: http://www.theinsightpartners.com/

About Us
The Insight Partners Is A One Stop Industry Research Provider Of Actionable Intelligence. We Help Our Clients In Getting Solutions To Their Research Requirements Through Our Syndicated And Consulting Research Services.
We Are Committed To Providing Highest Quality Research And Consulting Services To Our Customers. We Help Our Clients Understand Key Market Trends, Identify Opportunities, And Make Informed Decisions By Providing Market Research Solutions At An Affordable Cost.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drug Delivery Systems market is growing at a high cagr by 2027 according to a new research report by BD, Novo Nordisk A/S, 3M, Boston Scientific Corporation, Bausch Health Companies here

News-ID: 1800276 • Views: 507

More Releases from The Insight Partners

Automotive Logistics Market Comprehensive Evaluation of the Market via in-Depth …
According to a new market study entitled “Automotive Logistics Market to 2027 – Global Analysis and Forecasts by Deployment Type (On-Premise and Cloud) and Industry Vertical (BFSI, Healthcare & Life Sciences, Retail & Consumer Goods, Manufacturing, Travel & Hospitality, IT & Telecommunication, Media & Entertainment, and Others) and Geography, “explains the report, explaining the key drivers of this growth and highlighting key market players and their evolution. The report factors
Leisure Boats Market Comprehensive Evaluation of the Market via in-Depth Qualita …
According to a new market study entitled “Leisure Boats Market to 2027 – Global Analysis and Forecasts by Deployment Type (On-Premise and Cloud) and Industry Vertical (BFSI, Healthcare & Life Sciences, Retail & Consumer Goods, Manufacturing, Travel & Hospitality, IT & Telecommunication, Media & Entertainment, and Others) and Geography, “explains the report, explaining the key drivers of this growth and highlighting key market players and their evolution. The report factors
Clinical Decision Support System Market Recent trends, Global Status, Analysis b …
The support system also enables detection and helps in diagnosis of a prevailing diseases depending on the history of the patient. It is a part of clinical knowledge management technologies that supports the clinical process and use of knowledge, from diagnosis and investigation through treatment and long-term care. The CDSS application are commonly used to enhance healthcare provided to patients and help doctors or other medical professionals make decisions. The “The
Polymer Foam Market Future Scenario, Growth rate, Market Segmentation, and Indus …
The report aims to provide an overview of the Polymer Foam Market with detailed market segmentation by type, end user industry, and geography. The global polymer foam market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading polymer foam market players and offers key trends and opportunities in the market. The report also includes the profiles of key

All 5 Releases


More Releases for Drug

Biologics Drug Discovery Market
2019-2025 Biologics Drug Discovery Market Report with Depth Analysis The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization. The report presents a comprehensive overview, market size, shares, and growth opportunities of Biologics Drug Discovery market by product type, application, key manufacturers and key regions. Request For Free report Sample -https://www.reportsmonitor.com/request_sample/306320 Scope of the Report: Furthermore, Biologics Drug Discovery Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers or
Opioid Antagonist Drug Market
The global market has been prognosticated to earn demand from popular types of products such as external use, oral and applications such as household and hospital. The Company has made available another publication in its Healthcare archive of market intelligence reports, which is titled “Global Opioid Antagonist Drug Market Research Report 2018.” While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential
Drug and cosmetics
Drug and Cosmetics Conferences regards each one of the individuals to go to the On “Drug and Cosmetics” amidst October 17-October 18, 2018 in Toronto, Canada which melds brief keynote presentations, speaker talks, Exhibition, Symposia, Workshops. Drug and Cosmetics Congress is one of the meetings and conferences which will be visited by all the prestigious cosmetologists, Scientists, fiery inspectors, postgraduates, affiliations, business meanders under a solitary rooftop. DRug and cosmetics BLESSY MATHEW Program
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning